Sign In
Buy IPO
$56.85
-0.720 (-1.25%)
At Close: Jun 03, 2026
Oak Street Health's stock paces NYSE gainers on first day of trading
06:51pm, Thursday, 06'th Aug 2020
Shares of Oak Street Health Inc. debuted with a bang Thursday, as they paced all NYSE percentage gainers on their first day of trading, after the initial public offering priced above its expected ran
Quicken Loans parent Rocket Companies stock's debut falls flat, after downsized IPO price below expectations
03:27pm, Thursday, 06'th Aug 2020
Quicken Loans parent Rocket Companies Inc.'s stock public debut fell flat, after the mortgage lending giant's downsized initial public offering priced below its expected range. The stock's first trad
BigCommerce's stock nearly triples at the open, and keeps rising
05:04pm, Wednesday, 05'th Aug 2020
BigCommerce Holdings Inc.'s stock blasted off at the open, and kept rising, after provider of software that enables users to build out their online businesses's recently upsized initial public offeri
AlloVir prices upsized IPO at $17, to be valued at over $1 billion
12:53pm, Thursday, 30'th Jul 2020
AlloVir Inc. said Thursday that its upsized initial public offering priced at $17 a share, in the middle of the expected range of $16 to $18 a share. The company sold 16.25 million shares to raise $2
Quicken Loans parent Rocket Cos. to offer 150 million shares in IPO, priced at $20 to $22 each
11:46am, Tuesday, 28'th Jul 2020
Rocket Companies. Inc. , the parent of mortgage lending giant Quicken Loans, set terms for its initial public offering on Tuesday, with plans to offer 150 million shares, priced at $20 to $22 each. Th
IPO market braces for another 7 deals this week and yet another blank-check company
06:54pm, Monday, 27'th Jul 2020
The U.S. initial public offering market is gearing up for another week with seven deals and yet another blank-check company, led by tax software provider Vertex which is expected to have a $2 billion
Nurix Therapeutics shares slide 2.3% in trading debut
05:07pm, Friday, 24'th Jul 2020
Nurix Therapeutics Inc. shares fell 2.3% in their trading debut Friday, after pricing above the proposed price range. Nurix sold 11 million shares priced at $19 each, above a recently tweaked $17 to
Jamf's stock soars in its public debut, after IPO prices above expectations
04:15pm, Wednesday, 22'nd Jul 2020
Shares of Jamf Holding Corp. soared in their public debut, as the Apple Enterprise Management software provider's stock opened 77% above its initial public offering price, which above what was previo
Bill Ackman's Pershing Square Tontine goes public 5.5% above its IPO price
02:17pm, Wednesday, 22'nd Jul 2020
Shares of Pershing Square Tontine Holdings Ltd. , the "black check" company formed by billionaire hedge fund manager Bill Ackman, started trading Wednesday 5.5% above its initial public offering price
Bill Ackman's Pershing Square Tontine raises $4 billion as IPO prices at $20 a share
12:15pm, Wednesday, 22'nd Jul 2020
Pershing Square Tontine Holdings Ltd. , a special purpose acquisition (SPAC), or blank check company, formed by billionaire investor Bill Ackman, raised $4 billion as its initial public offering of 20
ITeos Therapeutics sets IPO terms, to value the company at up to $571.5 million
01:33pm, Monday, 20'th Jul 2020
ITeos Therapeutics Inc. disclosed Monday that it set terms of its initial public offering, in which the biopharmaceutical company focused on cancer treatments could raise up to $160.2 million and be
Nurix Therapeutics sets IPO terms, to be valued at up to $627 million
11:12am, Monday, 20'th Jul 2020
Nurix Therapeutics Inc. disclosed Monday the terms for its initial public offering, in which the San Francisco-based biopharmaceutical company focused on cancer treatments could raise up to $158.4 mi
Berkeley Lights stock more than doubles at its open, valuing the company at $3.1 billion
05:06pm, Friday, 17'th Jul 2020
Shares of Berkeley Lights Inc. took flight Friday, as the cell biology company went public at a price that was more than double what the upsized initial public offering was priced. The stock's first
Pandion Therapeutics stock shot up 50% at its open
04:03pm, Friday, 17'th Jul 2020
Pandion Therapeutics Inc. started its public life with a bang, as biotechnology company's stock opened 50% above where the upsized initial public offering was priced. The stock's first trade was at $
Pandion Therapeutics' upsized IPO priced at the top of the expected range
12:46pm, Friday, 17'th Jul 2020
Pandion Therapeutics Inc. raised more than expected in its initial public offering, which was upsized to 7.5 million shares and priced at $18. The biotechnology company was previously planning to sel
